Early Screening and Referral for Autism Spectrum and Neurodevelopmental Disorders in Infants Under 1 Year at Maternal and Child Protection Services in France
Led by Centre Hospitalier Intercommunal Creteil · Updated on 2025-06-13
10400
Participants Needed
1
Research Sites
104 weeks
Total Duration
AI-Summary
What This Trial Is About
This research aims to compare two methods of early screening to identify infants at risk for Autism Spectrum Disorder and Neurodevelopmental Disorders. It targets infants under 12 months of age to provide early access to care, hoping to improve outcomes by detecting developmental delays compared to typical age expectations. The study is conducted at multiple Maternal and Child Protection Services in France and follows infants up to 48 months of age.
Two screening approaches are evaluated during routine visits for vaccinations or developmental exams at 4 and 9 months. One method involves a health professional assessing neurodevelopment through routine observations of motor skills, vocalizations, babbling, and social interactions. The other method uses the PREAUT grid, a specific screening tool for autism spectrum disorders. Infants showing abnormal results are referred promptly to specialized centers for further advice and treatment when needed.
Participants will have follow-ups at 12, 24, and 36 months including developmental assessments like the Modified Checklist for Autism in Toddlers and the Child Development Inventory. Additional diagnostic tools are used if initial tests indicate concerns. The study also collects data on treatments received, parental psychological state, quality of life, and family impact. Health insurance data will track care pathways up to 48 months. The main outcome is the proportion of children diagnosed and receiving care before age one.
CONDITIONS
Brief Title
Early Detection and Referral for Autism and Neurodevelopmental Disorders at the Maternal and Child Protection Services
Research Team
C
Catherine DELMAS, MD
C
Camille JUNG, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Infants between 4 and 9 months of age followed up in participating Maternal and Child Protection Services for the fourth and ninth-month vaccinations
Availability of a personal telephone for at least one parent
Parents informed about data collection and active follow-up until 36 months and provide consent
Affiliated with a social security system or eligible for Medical assistance of the state
Ability to understand French or presence of a French-speaking relative
You will not qualify if you...
Infant with a severe neurological pathology such as encephalopathy
Refusal to participate in the study
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person) during routine medical follow-up
Diagnostic Evaluation
Duration - At 4 and 9 months of age
Participants undergo neurodevelopmental assessments using either routine practice evaluations or the PREAUT grid to detect early signs of developmental gaps or autism spectrum disorder.
2 visits aligned with routine vaccination and developmental examinations
Long-term Monitoring
Duration - Up to 36 months
Participants are followed up at 12, 24, and 36 months to assess development, including screenings with M-CHAT-R/F and IDE tests, and additional diagnostic assessments if results are abnormal.
Visits at 12, 24, and 36 months with additional assessments as needed
Care Pathway Observation
Duration - Up to 48 months
Participants' care pathways are monitored using health insurance claims data to evaluate treatments and interventions received up to 48 months of age.
No additional visits; data collected through health records
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Similar Trials
Early Intervention Program for Preschool Children With Developmental Disorders Including Autism Spectrum Disorder
Chatbot Program to Improve Well-being in Caregivers of Children Ages 6 to 11 with Autism Spectrum Disorder
Comparing Two School Programs to Reduce Anxiety and Improve Emotion Regulation in Autistic Students Ages 8 to 14
Online Parent-Training Program for Young Children With Autism or Social Communication Delays
Helping Families Access Early Intervention Remotely
Feasibility Study of an 8-Week Parent-Child Yoga Program to Improve Attention in Children Aged 4 to 6 with Congenital Heart Disease
Open-Label Study Testing DT402 in Adults with Autism Spectrum Disorder
Pilot Study of Digital Therapeutic NDTx-02 to Improve Executive Function in Children and Adolescents Ages 5 to 12 With ADHD or Autism Spectrum Disorder
Evaluating the Effects of Folinic Acid Treatment Compared to Placebo in Children Aged 3 to 6 Years with Autism Spectrum Disorder in a Double-Blind Randomized Trial
Prospective Birth Cohort Study on Allergies and Neurodevelopmental Disorders in Infants and Young Children in China
Online Self-Instructional Program for Kindergarten and Elementary Teachers to Support Autistic Children and Children With Developmental Delays
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Effectiveness of early detection and coordinated referral of infants before 1 year at risk for autism spectrum and neurodevelopmental disorders in maternal and child protection centre: a French randomised pragmatic trial in a stepped-wedge trial (PRECO-TSA protocol).